SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001213900-20-000834
Filing Date
2020-01-13
Accepted
2020-01-13 06:38:46
Documents
3
Period of Report
2020-01-13

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 6-K f6k011320a1_xtlbiopharma.htm 6-K/A 21522
2 NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S ANNUAL GENERAL MEETING f6k011320a1ex99-1_xtlbiophar.htm EX-99.1 116687
3 GRAPHIC ex99-1_001.jpg GRAPHIC 3193
  Complete submission text file 0001213900-20-000834.txt   143756
Mailing Address 5 HACHAROSHET ST. RAANANA L3 4365603
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K/A | Act: 34 | File No.: 001-36000 | Film No.: 20522693
SIC: 2834 Pharmaceutical Preparations